Skip to content

APTEVO THERAPEUTICS INC.

APVO

CIK 0001671584

← back to feed
Revenue (TTM)
$11.74M
−74.7% YoY Q1 May 2026
Net Income (TTM)
−$26.86M
−7.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1,598.85
+99.7% YoY Q1 May 2026
Gross Margin
-38.2%
Q1 May 2026
Operating Margin
-231.3%
Q1 May 2026
Net Margin
-228.8%
Q1 May 2026
Free Cash Flow (TTM)
−$18.24M
Q1 May 2026
Cash
$14.53M
Q1 May 2026
Total Debt
$3.46M
Q1 May 2026
Shares Outstanding
1.25M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings